LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1694 | 9760 | 11103 | 0.8790 | 0.9071 |
MCF 10A | XL147 | 10 | uM | LJP5 | 72 | hr | 1694 | 5776 | 11103 | 0.5203 | 0.5716 |
MCF 10A | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10738 | 11217 | 0.9573 | 0.9681 |
MCF 10A | Y39983 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 8937 | 11217 | 0.7967 | 0.8400 |
MCF 10A | Y39983 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 9405 | 11217 | 0.8385 | 0.8749 |
MCF 10A | Y39983 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 9085 | 11217 | 0.8100 | 0.8513 |
MCF 10A | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 8452 | 11217 | 0.7537 | 0.8028 |
MCF 10A | Y39983 | 10 | uM | LJP6 | 72 | hr | 1694 | 3290 | 11217 | 0.2935 | 0.2745 |
MCF 10A | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 1694 | 11315 | 11217 | 1.0086 | 1.0060 |
MCF 10A | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1694 | 10974 | 11217 | 0.9783 | 0.9839 |
MCF 10A | Nintedanib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 10967 | 11217 | 0.9776 | 0.9833 |
MCF 10A | Nintedanib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 10827 | 11217 | 0.9651 | 0.9740 |
MCF 10A | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1694 | 9454 | 11217 | 0.8429 | 0.8785 |
MCF 10A | Nintedanib | 10 | uM | LJP6 | 72 | hr | 1694 | 10976 | 11217 | 0.9784 | 0.9840 |
MCF 10A | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1694 | 11930 | 11103 | 1.0746 | 1.0537 |
MCF 10A | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 1694 | 11382 | 11103 | 1.0252 | 1.0184 |
MCF 10A | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1694 | 10225 | 11103 | 0.9209 | 0.9402 |
MCF 10A | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1694 | 5525 | 11103 | 0.4975 | 0.5452 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 72 | hr | 1694 | 2325 | 11103 | 0.2094 | 0.1238 |
MCF 10A | Foretinib | 10 | uM | LJP5 | 72 | hr | 1694 | 1417 | 11103 | 0.1276 | -0.0643 |
MCF 10A | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1694 | 10915 | 11217 | 0.9731 | 0.9801 |
MCF 10A | AZD 5438 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 9687 | 11217 | 0.8635 | 0.8951 |
MCF 10A | AZD 5438 | 0.37 | uM | LJP6 | 72 | hr | 1694 | 6413 | 11217 | 0.5717 | 0.6292 |
MCF 10A | AZD 5438 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 1677 | 11217 | 0.1495 | -0.0039 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 513 | 11217 | 0.0457 | -0.3571 |